-Search query
-Search result
Showing 1 - 50 of 58 items for (author: derking & r)

EMDB-48283: 
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48286: 
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48287: 
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48290: 
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48291: 
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-70490: 
BG505 GT1.1 SOSIP in complex with gp41-base epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70491: 
BG505 GT1.1 SOSIP in complex with V1V2V3 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70492: 
BG505 GT1.1 SOSIP in complex with C3V5 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70493: 
BG505 GT1.1 SOSIP in complex with CD4bs epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70494: 
BG505 GT1.1 SOSIP in complex with gp41 glycan hole epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70495: 
BG505 GT1.1 SOSIP in complex with gp41 fusion peptide epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

PDB-9mi0: 
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mia: 
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mib: 
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mih: 
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mii: 
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-41869: 
BG505.664 SOSIP in complex with polyclonal antibodies from NHP 8131 (gp120 glycan hole, gp41 glycan hole/fusion peptide and trimer base epitopes)
Method: single particle / : Zhang S, Ward AB

EMDB-41870: 
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8131 (gp120-gp120 interface epitope)
Method: single particle / : Zhang S, Ward AB

EMDB-41871: 
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8147 (C3/V5, V1/V2/V3 apex, gp41 glycan hole/fusion peptide and trimer base epitopes)
Method: single particle / : Zhang S, Ward AB

EMDB-41872: 
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8147 (gp120 glycan hole epitope)
Method: single particle / : Zhang S, Ward AB

EMDB-41972: 
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP A12N030 (CD4bs, C3V5 and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41973: 
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP A12N030 (gp41GH/FP and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41974: 
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (gp41GH/FP and gp120GH epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41975: 
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (gp120GH and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41976: 
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (V1V2V3 and gp120GH epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41977: 
GT1.1 SOSIP-CC2 in complex with wk80 polyclonal antibodies from NHP 8229 (V1V2V3, C3V5, CD4bs, gp41GH/FP and base epitopes)
Method: single particle / : Sewell LM, Ozorowski G, Ward AB

EMDB-41978: 
GT1.1 SOSIP-CC2 in complex with wk80 polyclonal antibodies from NHP 8239 (gp120GH, gp41GH/FP, CD4bs, and base epitopes)
Method: single particle / : Sewell LM, Ozorowski G, Ward AB

EMDB-40796: 
BG505 GT1.1 SOSIP in complex with NHP Fabs 12C11 and RM20A3
Method: single particle / : Zhang S, Torres JL, Ozorowski G, Ward AB

PDB-8sw3: 
BG505 GT1.1 SOSIP in complex with NHP Fabs 12C11 and RM20A3
Method: single particle / : Zhang S, Torres JL, Ozorowski G, Ward AB

EMDB-40797: 
BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
Method: single particle / : Ozorowski G, Torres JL, Zhang S, Ward AB

PDB-8sw4: 
BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
Method: single particle / : Ozorowski G, Torres JL, Zhang S, Ward AB

EMDB-22170: 
BG505 SOSIPv5.2 in complex with PGT122 and two RM20E1 Fabs
Method: single particle / : Cottrell CA, Ward AB

EMDB-22171: 
BG505 SOSIPv5.2 in complex with PGT122 and three RM20E1 Fabs
Method: single particle / : Cottrell CA, Ward AB

EMDB-22172: 
C3 symmetric BG505 SOSIPv5.2 in complex with PGT122 and three RM20E1 Fabs
Method: single particle / : Cottrell CA, Ward AB

EMDB-22173: 
BG505 SOSIPv5.2 in complex with PGT122 and one RM20E1 Fab
Method: single particle / : Cottrell CA, Ward AB

EMDB-22178: 
BG505 SOSIPv5.2 in complex with PGT122 and no RM20E1 Fabs
Method: single particle / : Cottrell CA, Ward AB

EMDB-22179: 
C3 symmetric BG505 SOSIPv5.2 in complex with PGT122 and no RM20E1 Fabs
Method: single particle / : Cottrell CA, Ward AB

EMDB-22061: 
negative stain EM map of SARS-CoV-2 spike in complex with COVA2-15 Fab
Method: single particle / : Ward AB, Bangaru S, Torres JL

EMDB-22062: 
negative stain EM map of SARS-CoV-2 spike in complex with COVA1-22
Method: single particle / : Ward AB, Bangaru S, Torres JL

EMDB-22063: 
negative stain EM map of SARS-CoV-2 spike in complex with COVA2-07
Method: single particle / : Ward AB, Bangaru S, Torres JL

EMDB-22064: 
negative stain EM map of SARS-CoV-2 spike in complex with COVA2-39 Fab
Method: single particle / : Ward AB, Bangaru S, Torres JL

EMDB-22065: 
negative stain EM map of SARS-CoV-2 spike in complex with COVA2-04 Fab
Method: single particle / : Ward AB, Bangaru S, Torres JL

EMDB-22066: 
negative stain EM map of SARS-CoV-2 spike in complex with COVA1-12 Fab
Method: single particle / : Ward AB, Bangaru S, Torres JL

EMDB-3067: 
cryoEM reconstruction of 3BC315 Fab in complex with BG505 SOSIP.664 Env trimer
Method: single particle / : Lee JH, Ward AB

EMDB-2853: 
3BNC117 Fab in complex with BG505 SOSIP.664 Trimer
Method: single particle / : Ozorowski G, Derking R, Sanders RW, Ward AB

EMDB-6249: 
1NC9 Fab in complex with BG505 SOSIP.664 Trimer
Method: single particle / : Ozorowski G, Derking R, Sanders RW, Ward AB

EMDB-6250: 
CH103 Fab in complex with BG505 SOSIP.664 Trimer
Method: single particle / : Ozorowski G, Derking R, Haynes B, Kwong PD, Sanders RW, Ward AB

EMDB-6251: 
CH106 Fab in complex with BG505 SOSIP.664 Trimer
Method: single particle / : Ozorowski G, Derking R, Sanders RW, Ward AB

EMDB-6252: 
VRC01 Fab in complex with BG505 SOSIP.664 Trimer
Method: single particle / : Torres JL, Ozorowski G, Derking R, Sanders RW, Ward AB

EMDB-6256: 
A native-like SOSIP.664 trimer based on a HIV-1 subtype B env gene
Method: single particle / : Pugach P, Ozorowski G
Pages:
Movie
Controller
Structure viewers
About EMN search



wwPDB to switch to version 3 of the EMDB data model
